Application Nr Approved Date Route Status External Links
ANDA210423 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For Adjunctive Treatment Of: Chronic Simple (Open-Angle) Glaucoma, Secondary Glaucoma, And Preoperatively In Acute Angle-Closure Glaucoma Where Delay Of Surgery Is Desired In Order To Lower Intraocular Pressure. Acetazolamide Extended-Release Capsules Are Also Indicated For The Prevention Or Amelioration Of Symptoms Associated With Acute Mountain Sickness Despite Gradual Ascent.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Acetazolamide ACETAZOLAMIDE ZINC3813042

Comments